Skip to main content
HOPA Abstracts
Factors Associated With Clinical Outcomes in Patients With HER2 Mutation–Positive NSCLC Who Received Sevabertinib (BAY 2927088)
Abstract #CR17
Katelyn Toeniskoetter, PharmD, BCOP
Read More
HOPA Abstracts
SOHO-01: Safety and Efficacy of Sevabertinib in Patients With Advanced HER2 Mutation–Positive Non–Small Cell Lung Cancer Who Received Pretreatment but Were Naïve to HER2-Targeted Therapy or Had Not Received Any Treatment for Advanced Disease
Abstract #CR18
Katelyn Toeniskoetter, PharmD, BCOP
Read More
HOPA Abstracts
Automating Dose Rounding Within the Electronic Health Record: Impact on Drug Waste and Cost Avoidance
Abstract #CR19
Sarah Hogue, PharmD;
Read More
HOPA Abstracts
Treatment Persistence and Dose Modifications in US Patients With Hormone Receptor–Positive, HER2-Negative, Node-Positive, Early Breast Cancer Treated With Adjuvant Abemaciclib
Abstract #CR20
Astra Liepa, PharmD, BS
Read More
HOPA Abstracts
Operational and Financial Impact of Electronic Medical Record–Integrated Biomarker Testing Workflows on Specialty Pharmacy in Non–Small Cell Lung Cancer
Abstract #CR21
Kelsey Schildknecht, PharmD; Lauren Gilmer, PharmD
Read More
HOPA Abstracts
Oxaliplatin Desensitization—A Promising Approach for Patients With Cancer and Hypersensitivity Reactions: Real-World Experience From Vietnam
Abstract #LB01
Le Trang Nguyen
Read More
HOPA Abstracts
Infusion Pharmacist–Driven Romiplostim Dosing Protocol to Optimize Efficiency in an Outpatient Hematology and Oncology Cancer Center
Abstract #LB02
Ashley Jones, PharmD, BCOP; Hetalkumari Patel, PharmD, BCOP; Kailee Gaines, PharmD, BCOP
Read More
HOPA Abstracts
Pharmacist-Led Management of Vorasidenib in Patients With Isocitrate Dehydrogenase Mutation–Positive Gliomas
Abstract #LB03
Marie Noelle Bate Baiyee, PharmD; Mary Hilliger, PharmD; Bilge Parlakkilic, PharmD
Read More
HOPA Abstracts
Building Real-World Evidence Through the HERO Consortium: A Pharmacist-Led Multicenter Initiative
Abstract #LB04
Ila M. Saunders, PharmD, BCOP; Sarah Profitt, PharmD, BCOP
Read More
HOPA Abstracts
Hybrid Observation Model for Bispecific T-Cell Engager
Abstract #LB05
Alyssa Cendagorta, PharmD, BCOP
Read More
Page 6 of 199
Results 51 - 60 of 1986